Announcements Trials

Browse Landscape

Phase

Phase NA 1 Phase 1/2 1

Status

Terminated 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Cancer Recurrent 1

Interventions

Bevacizumab 14 Injections 13 Drug Therapy 10 Gemcitabine 9 toripalimab 8 venetoclax 7 Specimen Handling 7 Magnetic Resonance Spectroscopy 7 Cyclophosphamide 7 Carboplatin 7 pembrolizumab 6 irinotecan sucrosofate 6 Temozolomide 6 HMPL-013 6 tislelizumab 5 sintilimab 5 fludarabine 5 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 5 Fluorouracil 5 Etoposide 5 Cisplatin 5 Biopsy 5 osimertinib 4 lenvatinib 4 Rituximab 4 Radiotherapy 4 Pemetrexed 4 Paclitaxel 4 Oxaliplatin 4 Leucovorin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Not yet recruiting × Re-Irradiation × Clear all

NCT07612254 2026-05-28

REPEAT

Dartmouth-Hitchcock Medical Center

Phase 1/2 Not yet recruiting

Breast Cancer Recurrent

Data powered by HemOnc (CC BY 4.0) Colophon ⚡